Comparison between Beta Drugs IPO and CMM Infraprojects IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while CMM Infraprojects IPO is a SME Fixed Price proposed to list at NSE SME.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Systematix Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Systematix Shares & Stocks (India) Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the CMM Infraprojects IPO is up to ₹17.27 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of CMM Infraprojects IPO is ₹40.00 per share.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹40.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 21,66,400 shares | 43,17,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹17.27 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 43,17,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹17.27 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while CMM Infraprojects IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and CMM Infraprojects IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 04, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 12, 2017 | Oct 12, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to CMM Infraprojects IPO P/E ratio of .
| Beta Drugs IPO | CMM Infraprojects IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹73.52 Cr. | ₹62.69 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in CMM Infraprojects IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in CMM Infraprojects IPO.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,29,600 shares | 2,28,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 21,57,000 shares |
| RII | 10,83,200 shares | 21,60,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 43,17,000 shares |
Beta Drugs IPO subscribed 18.97x in total, whereas CMM Infraprojects IPO subscribed 1.71x.
| Beta Drugs IPO | CMM Infraprojects IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 29.93x | 1.68x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.00x | 1.74x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.97x | 1.71x |
